Developing and Testing Mobile Health Question Prompt List in Gastroesophageal Reflux Disease
Developing, Refining, and Testing a Mobile Health Question Prompt List in Gastroesophageal Reflux Disease
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Study Type
Study Type
Enrollment (Estimated)
Enrollment
Phase
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
California
-
Stanford, California, United States, 94305
- Stanford University
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- clinical diagnosis of GERD
- GerdQ score of >=8
- documented PPI use for GERD
- internet access at home or computer/mobile device
- ability to provide written or e-consent.
Exclusion Criteria:
- Established diagnosis that mimic GERD symptoms (e.g. achalasia by prior esophageal manometry)
- non-English speaking patients
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Health Services Research
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Number of Arms
Arms and Interventions
Participant Group / ArmParticipant Group / Arm |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
No Intervention: Focus Group (Aim 1)
Participants give feedback about day-to-day challenges with GERD.
|
|
|
No Intervention: Focus Group (Aim 2)
Participants give feedback about mobile health app prototype
|
|
|
Experimental: mHealth app (Aim 3)
Participants will be exposed to an app-based question prompt list with gamification features to promote medication adherence as part of their communication with their health provider.
|
mHealth Question Prompt List app that facilitates in asking questions with a physician during a consultation specific to GERD
Other Names:
|
|
No Intervention: Standard of care (Aim 3)
Participants will be exposed to standard of care communication with their health provider (no mHealth app).
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Patient Activation Measure Scale Score
Time Frame: month 3
|
Patient Activation Measure is a measure of how much activation (knowledge and confidence) participants have in managing their health.
|
month 3
|
|
Patient Activation Measure Scale Score
Time Frame: month 6
|
Patient Activation Measure is a measure of how much activation (knowledge and confidence) participants have in managing their health.
|
month 6
|
Secondary Outcome Measures
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Pill Count
Time Frame: months 3 and 6
|
measures medication adherence
|
months 3 and 6
|
|
12-item Short Form Survey
Time Frame: months 3 and 6
|
patient survey that measures health related quality of life
|
months 3 and 6
|
|
Gerd-Q
Time Frame: months 3 and 6
|
patient survey that measures symptom severity of GERD
|
months 3 and 6
|
Collaborators and Investigators
Sponsor
Sponsor
Collaborators
Collaborators
Investigators
Investigators
- Principal Investigator: Afrin N Kamal, MD, Stanford University
Study record dates
Study Major Dates
Study Start (Estimated)
Study Start
Primary Completion (Estimated)
Primary Completion
Study Completion (Estimated)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Actual)
First Posted
Study Record Updates
Last Update Posted (Actual)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
Other Study ID Numbers
- 62297
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.